Average Co-Inventor Count = 7.47
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bracco International Bv (14 from 108 patents)
2. Bracco Suisse Sa (14 from 60 patents)
3. Dyax Corporation (9 from 173 patents)
4. Other (1 from 832,912 patents)
29 patents:
1. 9446155 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
2. 9408926 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
3. 9381258 - Targeting vector-phospholipid conjugates
4. 9295737 - Targeting vector-phospholipid conjugates
5. 9056138 - Multivalent constructs for therapeutic and diagnostic applications
6. 8663603 - Multivalent constructs for therapeutic and diagnostic applications
7. 8642010 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
8. 8632753 - Multivalent constructs for therapeutic and diagnostic applications
9. 8623822 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
10. 8551450 - Targeting vector-phospholipid conjugates
11. 8263739 - Compounds for targeting endothelial cells, compositions containing the same and methods for their use
12. 7985402 - Targeting vector-phospholipid conjugates
13. 7910088 - Multivalent constructs for therapeutic and diagnostic applications
14. 7884183 - Compounds for targeting endothelial cells, compositions containing the same and methods for their use
15. 7854919 - Multivalent constructs for therapeutic and diagnostic applications